Hsin-Lun Lee

https://orcid.org/0000-0002-2905-7858

Email132018@h.tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2014-2020 Ph.D., The Ph.D. Program for Translational Medicine, Taipei Medical University
2000-2007 M.D., School of Medicine, College of Medicine, Taipei Medical University

Experience

Attending Physician, Taipei Medical University Hospital
2021.01- Director, Division of Radiation Oncology, Taipei Medical University Hospital
2020.11- Assistant Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
2019.08-2020.12 Acting Director, Division of Radiation Oncology, Taipei Medical University Hospital
2014.04-2015.06 Adjunct Attending Physician, Taipei Medical University Hospital
2013.04-2014.09 Adjunct Attending Physician, Landseed International Hospital
2012.11-2015.06 Attending Physician, Taipei Municipal Wanfang Hospital

Fingerprint

Dive into the research topics where Hsin-Lun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

2 Finished

Stem Cell-Based Approaches and Organotypic Culture System for Dissecting Pathogenic Mechanisms and Establishing Therapeutic Strategies for Inflammatory Bowel Diseases and Gastrointestinal Cancer(3/3)
Lee, H.
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Investigating the Dynamic Change of Genotype and Phenotype in Circulating Tumor Cells and Its Clinical Significance in Cancer Progression
Lee, H.
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology

25 Citations
3 h-Index
11 Article

A combined systemic strategy for overcoming cisplatin resistance in head and neck cancer: From target identification to drug discovery
Chen, Y. J., You, G. R., Lai, M. Y., Lu, L. S., Chen, C. Y., Ting, L. L., Lee, H. L., Kanno, Y., Chiou, J. F. & Cheng, A. J., Nov 2020, In: Cancers. 12, 11, p. 1-20 20 p., 3482.
Research output: Contribution to journal › Article › peer-review

Open Access
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer
Lee, H. L., Chiou, J. F., Wang, P. Y., Lu, L. S., Shen, C. N., Hsu, H. L., Burnouf, T., Ting, L. L., Chou, P. C., Chung, C. L., Lee, K. L., Shiah, H. S., Liu, Y. L. & Chen, Y. J., Nov 2020, In: Cancers. 12, 11, p. 1-17 17 p., 3394.
Research output: Contribution to journal › Article › peer-review

Open Access
Molecular-clinical correlation in pediatric medulloblastoma: A cohort series study of 52 cases in Taiwan
Wu, K. S., Ho, D. M. T., Jou, S. T., Yu, A. L., Tran, H. M., Liang, M. L., Chen, H. H., Lee, Y. Y., Chen, Y. W., Lin, S. C., Chang, F. C., Tsai, M. L., Liu, Y. L., Lee, H. L., Hsieh, K. L. C., Huang, W. C., Sung, S. Y., Chang, C. C., Changou, C. A., Liang, K. H. & 7 others, Hsieh, T. H., Liu, Y. R., Chao, M. E., Chen, W., Chu, S. S., Cho, E. C. & Wong, T. T., Mar 2020, In: Cancers. 12, 3, 653.
Research output: Contribution to journal › Article › peer-review

Open Access
Upregulation of protein synthesis and proteasome degradation confers sensitivity to proteasome inhibitor bortezomib in myc-atypical teratoid/rhabdoid tumors
Tran, H. M., Wu, K. S., Sung, S. Y., Changou, C. A., Hsieh, T. H., Liu, Y. R., Liu, Y. L., Tsai, M. L., Lee, H. L., Hsieh, K. L. C., Huang, W. C., Liang, M. L., Chen, H. H., Lee, Y. Y., Lin, S. C., Ho, D. M. T., Chang, F. C., Chao, M. E., Chen, W., Chu, S. S. & 4 others, Yu, A. L., Yen, Y., Chang, C. C. & Wong, T. T., Mar 22 2020, In: Cancers. 12, 3, 752.
Research output: Contribution to journal › Article › peer-review

Open Access
Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization
Lee, H. L., Tsai, J. T., Chen, C. Y., Lin, Y. C., Ho, C. B., Ting, L. L., Kuo, C. C., Lai, I. C., Lin, C. Y., Tang, J. H., Huang, Y. M., Kao, W. Y., Cheng, S. W., Shen, C. N., Chen, S. W. & Chiou, J. F., Jan 1 2019, In: Therapeutic Advances in Medical Oncology. 11
Research output: Contribution to journal › Article › peer-review

Open Access

Education

Experience

Stem Cell-Based Approaches and Organotypic Culture System for Dissecting Pathogenic Mechanisms and Establishing Therapeutic Strategies for Inflammatory Bowel Diseases and Gastrointestinal Cancer(3/3)

Investigating the Dynamic Change of Genotype and Phenotype in Circulating Tumor Cells and Its Clinical Significance in Cancer Progression

A combined systemic strategy for overcoming cisplatin resistance in head and neck cancer: From target identification to drug discovery

Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer

Molecular-clinical correlation in pediatric medulloblastoma: A cohort series study of 52 cases in Taiwan

Upregulation of protein synthesis and proteasome degradation confers sensitivity to proteasome inhibitor bortezomib in myc-atypical teratoid/rhabdoid tumors

Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization